
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0UI8 market cap is 8.91M. The company's latest EPS is USD -12.6770 and P/E is -0.35.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -55.77M | -65.45M | -42.6M | -52.36M | -26.26M |
Net Income | -55.24M | -65.35M | -41.82M | -51.21M | -25.43M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 126.26M | 82.53M | 51.03M | 12.99M | 10.13M |
Total Liabilities | 7.35M | 8.29M | 13.29M | 15.89M | 14.67M |
Total Equity | 118.92M | 74.24M | 37.74M | -2.9M | -4.54M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -33.89M | -43.3M | -32.32M | -44.59M | -35.98M |
Investing | 12.63M | -35.21M | 30.07M | 9.96M | 18k |
Financing | 58.81M | 226k | 116k | 6.91M | 33.41M |
Market Cap | 8.91M |
Price to Earnings Ratio | -0.35 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.45 |
Price to Book Ratio | -1.96 |
Dividend Yield | - |
Shares Outstanding | 2.01M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 3 |
52 Week Change | -99.78% |
52 Week High | 1,998.00 |
52 Week Low | 4.44 |
Spread (Intraday) | 0 (0%) |
Company Name | Aptose Biosciences Inc |
Address |
5955 airport road mississauga, ontario L4V 1R9 |
Website | https://www.aptose.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions